(3S)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-ium-3-carboxylate

Details

Top
Internal ID 322f4836-e8ee-4224-8905-cf7b517da7b8
Taxonomy Organoheterocyclic compounds > Indoles and derivatives > Pyridoindoles > Beta carbolines
IUPAC Name (3S)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-ium-3-carboxylate
SMILES (Canonical) C1C([NH2+]CC2=C1C3=CC=CC=C3N2)C(=O)[O-]
SMILES (Isomeric) C1[C@H]([NH2+]CC2=C1C3=CC=CC=C3N2)C(=O)[O-]
InChI InChI=1S/C12H12N2O2/c15-12(16)10-5-8-7-3-1-2-4-9(7)14-11(8)6-13-10/h1-4,10,13-14H,5-6H2,(H,15,16)/t10-/m0/s1
InChI Key FSNCEEGOMTYXKY-JTQLQIEISA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C12H12N2O2
Molecular Weight 216.24 g/mol
Exact Mass 216.089877630 g/mol
Topological Polar Surface Area (TPSA) 72.50 Ų
XlogP -0.50
Atomic LogP (AlogP) -1.09
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (3S)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-ium-3-carboxylate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9857 98.57%
Caco-2 - 0.5505 55.05%
Blood Brain Barrier + 0.8000 80.00%
Human oral bioavailability - 0.5286 52.86%
Subcellular localzation Lysosomes 0.3318 33.18%
OATP2B1 inhibitior - 0.8597 85.97%
OATP1B1 inhibitior + 0.9043 90.43%
OATP1B3 inhibitior + 0.9466 94.66%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior - 0.7338 73.38%
P-glycoprotein inhibitior - 0.9867 98.67%
P-glycoprotein substrate - 0.8623 86.23%
CYP3A4 substrate + 0.5179 51.79%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7882 78.82%
CYP3A4 inhibition - 0.9268 92.68%
CYP2C9 inhibition - 0.9396 93.96%
CYP2C19 inhibition - 0.7199 71.99%
CYP2D6 inhibition - 0.6104 61.04%
CYP1A2 inhibition + 0.6022 60.22%
CYP2C8 inhibition - 0.7134 71.34%
CYP inhibitory promiscuity - 0.9283 92.83%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8800 88.00%
Carcinogenicity (trinary) Non-required 0.7265 72.65%
Eye corrosion - 0.9912 99.12%
Eye irritation - 0.6616 66.16%
Skin irritation - 0.7812 78.12%
Skin corrosion - 0.9424 94.24%
Ames mutagenesis - 0.6600 66.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6331 63.31%
Micronuclear + 0.7100 71.00%
Hepatotoxicity + 0.5659 56.59%
skin sensitisation - 0.8865 88.65%
Respiratory toxicity + 0.6778 67.78%
Reproductive toxicity + 0.9333 93.33%
Mitochondrial toxicity + 0.8250 82.50%
Nephrotoxicity - 0.8304 83.04%
Acute Oral Toxicity (c) III 0.5179 51.79%
Estrogen receptor binding - 0.7151 71.51%
Androgen receptor binding - 0.4928 49.28%
Thyroid receptor binding - 0.7509 75.09%
Glucocorticoid receptor binding - 0.7151 71.51%
Aromatase binding - 0.5774 57.74%
PPAR gamma + 0.7029 70.29%
Honey bee toxicity - 0.8862 88.62%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.5800 58.00%
Fish aquatic toxicity - 0.5629 56.29%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.06% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 94.65% 94.45%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.85% 95.56%
CHEMBL2535 P11166 Glucose transporter 91.04% 98.75%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 89.86% 96.09%
CHEMBL216 P11229 Muscarinic acetylcholine receptor M1 88.13% 94.23%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 86.12% 99.23%
CHEMBL2581 P07339 Cathepsin D 85.02% 98.95%
CHEMBL3310 Q96DB2 Histone deacetylase 11 84.97% 88.56%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 82.91% 94.62%

Cross-Links

Top
PubChem 6920044
NPASS NPC217372
ChEMBL CHEMBL155546